Shares of Carl Zeiss Meditec AG (ETR:AFX – Get Free Report) were up 1.1% during mid-day trading on Tuesday . The company traded as high as €104.70 ($111.38) and last traded at €103.40 ($110.00). Approximately 81,691 shares were traded during mid-day trading, a decline of 13% from the average daily volume of 94,405 shares. The stock had previously closed at €102.30 ($108.83).
Carl Zeiss Meditec Trading Up 1.1 %
The company has a debt-to-equity ratio of 7.16, a current ratio of 3.40 and a quick ratio of 2.47. The stock has a market capitalization of $9.25 billion, a PE ratio of 33.35, a PEG ratio of 3.86 and a beta of 0.92. The stock’s 50 day simple moving average is €113.29 and its two-hundred day simple moving average is €97.75.
Carl Zeiss Meditec Company Profile
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders.
Featured Articles
- Five stocks we like better than Carl Zeiss Meditec
- 10 Best Airline Stocks to Buy
- Silicon Motion Proves That AI in Motion Stays in Motion
- The How and Why of Investing in Gold Stocks
- Undervalued UnitedHealth Group Won’t Be For Long
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- The 5 Stocks Most Sold By Insiders This Year
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.
